Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.43 |
| ▸ | CNR1 | P21554 | 5/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.38 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12377280 | 0.91 | GAA (0.39) | KMT2ANPC1RAB9ASMN1; SMN2P2RX3 | |
| SCHEMBL12377291 | 0.91 | MET (0.43) | KMT2ANPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL12377283 | 0.89 | MAPT (0.42) | KMT2ANPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL12412022 | 0.87 | NPC1 (0.55) | KMT2ANPC1RAB9ASMN1; SMN2CNR1 | |
| SCHEMBL12377284 | 0.87 | MAPT (0.40) | KMT2ANPC1RAB9ASMN1; SMN2P2RX3 | |
| SCHEMBL12377282 | 0.83 | MAPT (0.48) | KMT2ANPC1RAB9ASMN1; SMN2P2RX3 | |
| SCHEMBL12377281 | 0.83 | P2RX3 (0.44) | SMN1; SMN2P2RX3CNR1MAPT | |
| SCHEMBL12377314 | 0.81 | MEN1 (0.40) | KMT2ASMN1; SMN2MEN1HTT | |
| SCHEMBL12412030 | 0.79 | NPC1 (0.44) | KMT2ANPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL12413900 | 0.78 | NPC1 (0.49) | KMT2ANPC1RAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7989422-B2 | Antibacterial agents | ALCHEMIA LIMITED (AU) | 2011-08-02 | — | — | US | disclosed |
| US-20090023669-A1 | Antibacterial Agents | ALCHEMIA LIMITED (AU) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023669-A1 | Antibacterial Agents | MRPL21, FUT6, FUT5 | KMT2A 4563/4885NPC1 1617/4885RAB9A 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.